NCT05103904
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05103904
Title Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Mayo Clinic Arizona Scottsdale Arizona 85259 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field